Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant-Reference-Cited by-同舟云学术

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

Published:2022-11 Issue:11 Volume:30 Page:1540-1555.e15
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Saito Akatsuki,Tamura Tomokazu,Zahradnik Jiri,Deguchi Sayaka,Tabata Koshiro,Anraku Yuki,Kimura Izumi,Ito Jumpei,Yamasoba Daichi,Nasser Hesham,Toyoda Mako,Nagata Kayoko,Uriu Keiya,Kosugi Yusuke,Fujita Shigeru,Shofa Maya,Monira Begum MST,Shimizu Ryo,Oda Yoshitaka,Suzuki Rigel,Ito Hayato,Nao Naganori,Wang Lei,Tsuda Masumi,Yoshimatsu Kumiko,Kuramochi Jin,Kita Shunsuke,Sasaki-Tabata Kaori,Fukuhara Hideo,Maenaka Katsumi,Yamamoto Yuki,Nagamoto Tetsuharu,Asakura Hiroyuki,Nagashima Mami,Sadamasu Kenji,Yoshimura Kazuhisa,Ueno Takamasa,Schreiber Gideon,Takaori-Kondo Akifumi,Shirakawa Kotaro,Sawa Hirofumi,Irie Takashi,Hashiguchi Takao,Takayama Kazuo,Matsuno Keita,Tanaka Shinya,Ikeda Terumasa,Fukuhara Takasuke,Sato Kei^ORCID

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference90 articles.

1. Phenix: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr.,2010

2. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5;Arora;Lancet Infect. Dis.,2022

3. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Barnes;Nature,2020

4. Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies;Bruel;Nat. Med.,2022

5. Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75;Cao;Preprint at bioRxiv,2022

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants;Nature Communications;2024-01-29

2. Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness;Viruses;2024-01-25

3. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants;Nature Microbiology;2024-01-16

4. Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages;Frontiers in Medicine;2024-01-15

5. Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance;Antimicrobial Agents and Chemotherapy;2024-01-10